BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yamada Y. Nucleic Acid Drugs-Current Status, Issues, and Expectations for Exosomes. Cancers (Basel) 2021;13:5002. [PMID: 34638486 DOI: 10.3390/cancers13195002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Hussain H, Ganesh A, Milane L, Amiji M. Lessons learned from the SARS-CoV-2 pandemic; from nucleic acid nanomedicines, to clinical trials, herd immunity, and the vaccination divide. Expert Opin Drug Deliv 2023;:1-18. [PMID: 36890642 DOI: 10.1080/17425247.2023.2189697] [Reference Citation Analysis]
2 Liu SS, Yu T, Qiao YF, Gu SX, Chai XL. Research on Hepatocyte Regulation of PCSK9-LDLR and Its Related Drug Targets. Chin J Integr Med 2023. [PMID: 36913119 DOI: 10.1007/s11655-023-3545-z] [Reference Citation Analysis]
3 Guo X, Gao C, Yang DH, Li S. Exosomal circular RNAs: A chief culprit in cancer chemotherapy resistance. Drug Resist Updat 2023;67:100937. [PMID: 36753923 DOI: 10.1016/j.drup.2023.100937] [Reference Citation Analysis]
4 Xiang X, Chen J, Jiang T, Yan C, Kang Y, Zhang M, Xiang K, Guo J, Jiang G, Wang C, XiangXu, Yang X, Chen Z. Milk-derived exosomes carrying siRNA-KEAP1 promote diabetic wound healing by improving oxidative stress. Drug Deliv Transl Res 2023;:1-11. [PMID: 36749479 DOI: 10.1007/s13346-023-01306-x] [Reference Citation Analysis]
5 Huang X, Guo H, Wang L, Zhang Z, Zhang W. Biomimetic cell membrane-coated nanocarriers for targeted siRNA delivery in cancer therapy. Drug Discov Today 2023;28:103514. [PMID: 36736580 DOI: 10.1016/j.drudis.2023.103514] [Reference Citation Analysis]
6 Oliveira RJ, da Silveira IOMF, das Neves SC, Mitsuyasu B, Martins AC, Berno C, Mohammad J, Raj H, de Araujo FHS, Hortelan CR, Machado L, da Silva Júnior EN, Vilela MLB, Nascimento VA, Beatriz A, da Silva Gomes R. ZIM, a Norbornene Derived from 4-Aminoantipyrine, Induces DNA Damage and Cell Death but in Association Reduces the Effect of Commercial Chemotherapeutics. Chem Res Toxicol 2023;36:66-82. [PMID: 36548215 DOI: 10.1021/acs.chemrestox.2c00275] [Reference Citation Analysis]
7 Morihiro K, Osumi H, Morita S, Hattori T, Baba M, Harada N, Ohashi R, Okamoto A. Oncolytic Hairpin DNA Pair: Selective Cytotoxic Inducer through MicroRNA-Triggered DNA Self-Assembly. J Am Chem Soc 2023;145:135-42. [PMID: 36538570 DOI: 10.1021/jacs.2c08974] [Reference Citation Analysis]
8 D'Souza A, Nozohouri S, Bleier BS, Amiji MM. CNS Delivery of Nucleic Acid Therapeutics: Beyond the Blood-Brain Barrier and Towards Specific Cellular Targeting. Pharm Res 2023;40:77-105. [PMID: 36380168 DOI: 10.1007/s11095-022-03433-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Padmakumar S, D'Souza A, Parayath NN, Bleier BS, Amiji MM. Nucleic acid therapies for CNS diseases: Pathophysiology, targets, barriers, and delivery strategies. J Control Release 2022;352:121-45. [PMID: 36252748 DOI: 10.1016/j.jconrel.2022.10.018] [Reference Citation Analysis]
10 Furuhashi T, Weckwerth W. Isomer analysis by mass spectrometry in clinical science. TrAC Trends in Analytical Chemistry 2022. [DOI: 10.1016/j.trac.2022.116907] [Reference Citation Analysis]
11 Musumeci L, Eilenberg W, Pincemail J, Yoshimura K, Sakalihasan N. Towards Precritical Medical Therapy of the Abdominal Aortic Aneurysm. Biomedicines 2022;10. [PMID: 36551822 DOI: 10.3390/biomedicines10123066] [Reference Citation Analysis]
12 Umare M, A. Alkathiri F, Chikhale R. Development of Nucleic Acid Targeting Molecules: Molecular Docking Approaches and Recent Advances. Biomedical Engineering 2022. [DOI: 10.5772/intechopen.107349] [Reference Citation Analysis]
13 Pandey SK, Singh RK. Recent developments in nucleic acid-based therapies for Parkinson’s disease: Current status, clinical potential, and future strategies. Front Pharmacol 2022;13:986668. [DOI: 10.3389/fphar.2022.986668] [Reference Citation Analysis]
14 Han Q, Fu H, Chu X, Wen R, Zhang M, You T, Fu P, Qin J, Cui T. Research advances in treatment methods and drug development for rare diseases. Front Pharmacol 2022;13:971541. [DOI: 10.3389/fphar.2022.971541] [Reference Citation Analysis]
15 Sharma P, Kumar A, Agarwal T, Dey AD, Moghaddam FD, Rahimmanesh I, Ghovvati M, Yousefiasl S, Borzacchiello A, Mohammadi A, Yella VR, Moradi O, Sharifi E. Nucleic acid-based therapeutics for dermal wound healing. Int J Biol Macromol 2022;220:920-33. [PMID: 35987365 DOI: 10.1016/j.ijbiomac.2022.08.099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Nteli P, Bajwa DE, Politakis D, Michalopoulos C, Kefala-Narin A, Efstathopoulos EP, Gazouli M. Nanomedicine approaches for treatment of hematologic and oncologic malignancies. World J Clin Oncol 2022; 13(7): 553-566 [DOI: 10.5306/wjco.v13.i7.553] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Kim Y, Kim H, Kim EH, Jang H, Jang Y, Chi SG, Yang Y, Kim SH. The Potential of Cell-Penetrating Peptides for mRNA Delivery to Cancer Cells. Pharmaceutics 2022;14:1271. [PMID: 35745843 DOI: 10.3390/pharmaceutics14061271] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
18 Matsuzaka Y, Yashiro R. Extracellular Vesicles as Novel Drug-Delivery Systems through Intracellular Communications. Membranes 2022;12:550. [DOI: 10.3390/membranes12060550] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
19 Yang L, Jia J, Li S. Advances in the Application of Exosomes Identification Using Surface-Enhanced Raman Spectroscopy for the Early Detection of Cancers. Front Bioeng Biotechnol 2022;9:808933. [DOI: 10.3389/fbioe.2021.808933] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 Seyednejad SA, Sartor GC. Noncoding RNA therapeutics for substance use disorder. Adv Drug Alcohol Res 2022;2:10807. [PMID: 36601439 DOI: 10.3389/adar.2022.10807] [Reference Citation Analysis]